Inventor · disambiguated record
Cornelius Pompe
Also filed as: POMPE CORNELIUS
9 granted patents·6 pending applications·58 citations·filing 2010–2025
86Inventor score
Top patents by PatentIndex Score
15 records- 0195US10301391B2BCMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted May 28, 2019·28 cites·19 claims
- 0292US10781264B2PSMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted Sep 22, 2020·8 cites·22 claims
- 0391US11434302B2Bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted Sep 6, 2022·7 cites·19 claims
- 0488US11419933B2Pharmaceutical composition comprising bispecific antibody constructsAMGEN INC·Filed 2017·Granted Aug 23, 2022·9 cites·19 claims
- 0584US11352433B2BCMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2019·Granted Jun 7, 2022·2 cites·23 claims
- 0677US9358275B2Factor VII compositionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jun 7, 2016·2 cites·19 claims
- 0772US2023192884A1Bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 0871US9029316B2Factor VII compositionBARDAT ANNIE·Filed 2010·Granted May 12, 2015·2 cites·19 claims
- 0969US12428491B2PSMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2020·Granted Sep 30, 2025·0 cites·28 claims
- 1068US2025333537A1Psma and cd3 bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 1168US2025163177A1Bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 1263US2023103401A1Pharmaceutical composition comprising bispecific antibody constructsAMGEN INC·Filed 2022·Application pending·0 cites
- 1355US9968662B2Factor VII compositionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Granted May 15, 2018·0 cites·19 claims
- 1454US2025368737A1Low ph pharmaceutical composition comprising t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 1547US2020332000A1Low ph pharmaceutical composition comprising t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cornelius Pompe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →